IQVIA Holdings Inc (IQV) Gets a Buy Rating from Morgan Stanley
Morgan Stanley analyst Ricky Goldwasser maintained a Buy rating on IQVIA Holdings Inc (IQV) today and set a price target of $145. The company’s shares closed on Friday at $125.07.
According to TipRanks.com, Goldwasser is a 3-star analyst with an average return of 3.0% and a 56.2% success rate. Goldwasser covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Quest Diagnostics Inc, and Charles River Labs.
Currently, the analyst consensus on IQVIA Holdings Inc is a Moderate Buy with an average price target of $142.14.
See today’s analyst top recommended stocks >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IQVIA Holdings, Inc. is a biotechnology company, which engages in healthcare development in the provision of professional services, information technology, and partnering solutions to the pharmaceutical services and healthcare industries. The company was founded by Dennis Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.